Skip to content

Early life exposure to antibiotics and mental health disorders later in life

Early life exposure to antibiotics and mental health disorders in childhood and adolescence

Status
Completed
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12617000718347
Acronym
None
Enrollment
221139
Registered
2017-05-17
Start date
2017-10-09
Completion date
2018-11-19
Last updated
2019-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

While mental illness affects 20% of Canadians of all ages, youth and children are at greater risk with a total number of staggering 3.2 million children at risk of developing depression. Seventy percent of mental health problems have their onset during childhood or adolescence. According to the Manitoba Center for Health Policy (MCHP), 11 % of children in Manitoba is prescribed at least one antidepressant over the course of a year. The rate of anxiolytic, antipsychotic and psychostimulant prescriptions in Manitoba’s children has been increasing over the last decades, and the prevalence of pervasive development disorders doubled during a ten-year study period. While a complex interplay of genetic, biological, personality and environmental factors have been identified for the etiology, the role of antibiotics is unknown. Animal models have demonstrated significant association between exposure to antibiotics and behavioral changes in mice. To date, no human study has been conducted to assess this association. To bridge the gap in the literature, this study is aimed to provide insight into the role of antibiotics in the development of a wide range of mental health/ psychiatric disorders including attention deficiet hyperactivity disorder , autism spectrum disorders, mood and anxiety disorders, psychiatric disorders, schizophrenia, developmental disorders, suicidal attempts, substance use disorders and conduct disorders. Proving a clear association between the use of antibiotics in pregnant women and their offspring, and development of psychological and behavioral disorders later in life will send a paradigm-shifting message to mothers and physicians to be cautious about prescribing and using antibiotics in pregnancy and early childhood.

Interventions

Within a retrospective cohort design, exposure to antibiotics during pregnancy and the first 3 years of life were evaluated with respect to the frequency of exposure, gestational and postnatal age at exposure, antibiotic class, and type. The participants have already been followed up for a maximum of 16 years from the third birth date. Data will be collected from medical records, hospital discharge abstracts and drug information network. All these changes were made before the enrollment commenc

Within a retrospective cohort design, exposure to antibiotics during pregnancy and the first 3 years of life were evaluated with respect to the frequency of exposure, gestational and postnatal age at exposure, antibiotic class, and type. The participants have already been followed up for a maximum of 16 years from the third birth date. Data will be collected from medical records, hospital discharge abstracts and drug information network. All these changes were made before the enrollment commencement but was not updated here

Sponsors

Mahin Delara
Lead SponsorIndividual

Eligibility

Sex/Gender
All
Age
3 Years to 19 Years
Healthy volunteers
Yes

Inclusion criteria

All children who were exposed to antibiotics during fetal period and the first 3 years of life

Exclusion criteria

No exclusion criteria

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026